NASDAQ:TNGX - Tango Therapeutics Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $16.50
  • Forecasted Upside: 59.42 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$10.35
▼ -0.06 (-0.58%)

This chart shows the closing price for TNGX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Tango Therapeutics Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for TNGX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TNGX

Analyst Price Target is $16.50
▲ +59.42% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Tango Therapeutics in the last 3 months. The average price target is $16.50, with a high forecast of $17.00 and a low forecast of $16.00. The average price target represents a 59.42% upside from the last price of $10.35.

This chart shows the closing price for TNGX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 4 investment analysts is to buy stock in Tango Therapeutics.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/4/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/1/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/1/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/30/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/28/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/27/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/26/2021

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/20/2021SVB LeerinkInitiated CoverageOutperformHigh
9/7/2021WedbushInitiated CoverageOutperformHigh
9/7/2021GuggenheimInitiated CoverageBuy$16.00High
9/7/2021The Goldman Sachs GroupInitiated CoverageBuy$17.00High
(Data available from 11/27/2016 forward)

News Sentiment Rating

0.32 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/1/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/31/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/29/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/28/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
10/28/2021
  • 1 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
11/27/2021

Current Sentiment

  • 1 very positive mentions
  • 12 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Tango Therapeutics logo
Tango Therapeutics Inc. is a biotechnology company. It focused on discovering and delivering precision cancer medicines. Tango Therapeutics Inc., formerly known as BCTG Acquisition Corp., is based in CAMBRIDGE, Mass.
Read More

Today's Range

Now: $10.35
Low: $10.02
High: $10.74

50 Day Range

MA: $13.51
Low: $9.55
High: $17.30

52 Week Range

Now: $10.35
Low: $8.90
High: $18.84

Volume

49,256 shs

Average Volume

95,764 shs

Market Capitalization

$906.10 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.23

Frequently Asked Questions

What sell-side analysts currently cover shares of Tango Therapeutics?

The following Wall Street research analysts have issued stock ratings on Tango Therapeutics in the last twelve months: Guggenheim, SVB Leerink LLC, The Goldman Sachs Group, Inc., Wedbush, and Zacks Investment Research.
View the latest analyst ratings for TNGX.

What is the current price target for Tango Therapeutics?

2 Wall Street analysts have set twelve-month price targets for Tango Therapeutics in the last year. Their average twelve-month price target is $16.50, suggesting a possible upside of 59.4%. The Goldman Sachs Group, Inc. has the highest price target set, predicting TNGX will reach $17.00 in the next twelve months. Guggenheim has the lowest price target set, forecasting a price of $16.00 for Tango Therapeutics in the next year.
View the latest price targets for TNGX.

What is the current consensus analyst rating for Tango Therapeutics?

Tango Therapeutics currently has 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe TNGX will outperform the market and that investors should add to their positions of Tango Therapeutics.
View the latest ratings for TNGX.

How do I contact Tango Therapeutics' investor relations team?

Tango Therapeutics' physical mailing address is 12860 EL CAMINO REAL SUITE 300, SAN DIEGO CA, 92130. The company's listed phone number is 858-400-3120. The official website for Tango Therapeutics is www.tangotx.com.